摘要
探讨超敏C反应蛋白(hs-CRP)、血管性血友病因子(von Willebrand factor,vWF)、血小板表面P选择素(CD62P)的变化与冠心病患者的关系及其临床价值。对40例冠心病患者(不稳定性心绞痛)及30名正常人采用乳胶增强免疫比浊法测定hs-CRP,ELISA测血浆vWF,流式细胞仪(FCM)测定血小板膜CD62P阳性百分率(%)。结果显示,冠心病组的hs-CRP显著高于对照组(P<0.01),血浆vWF显著高于对照组(P<0.01),CD62P阳性率显著高于对照组(P<0.01)。联合检测hs-CRP、vWF和CD62P对冠心病患者的辅助诊断、疗效和预后观察有一定价值。
To explore the changes and clinical value of serum hs-CRP, vWF and CD62P levels in patients with coronary heart disease, the serum hs-CRP level was measured by latex enhanced immunoturbidimetry, the plasma vWF level was detected by ELISA and the percentage of CD62P in citrated whole blood was detected by flow cytometry in 40 patients with coronary heart disease （unstable angina） and 30 health controls. The results showed that the serum levels of hs-CRP and vWF in patients with coronary heart disease were higher than those in the healthy controls （P〈0. 01）. The percentage of CD62P in patients with coronary heart disease was higher than that in the healthy group （P〈0. 01）. These data suggest that combined detection of hs-CRP, vWF and CD62P levels in patients with coronary disease might have clinical significance in the supplementary diagnosis, the observation of curative and prognostic effect.
出处
《标记免疫分析与临床》
CAS
2008年第3期136-138,149,共4页
Labeled Immunoassays and Clinical Medicine
